Legislative instrument

• Replacement date: 24 November 2023

  Replacement type: Rectification

  Reason: To remove the table row containing “MP”, “C6661 C6662 C6678”, “P6661”, “15”, “5” and “C” from the entry for Granisetron in Schedule 2 as the text was incorrectly left in the compilation and belonged to the repealed entry for Interferon alfa-2a. To remove the entry for the form Injection 9,000,000 I.U. in 0.5 mL single dose pre-filled syringe from Granisetron in Schedule 2 as the form was incorrectly left in the compilation and belonged to the repealed entry for Interferon alfa-2a. To insert “Compliance with Authority Required procedures” in the column headed “Authority Requirements (part of Circumstances)” for the Circumstances Code C14587 in the entry for Blinatumomab in Schedule 4 as the text was not incorporated during the compilation process. To insert “Compliance with Written Authority Required procedures” in the column headed “Authority Requirements (part of Circumstances)” for the Circumstances Codes C14588 and C14631 in the entry for Blinatumomab in Schedule 4 as the text was not incorporated during the compilation process.
  • National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011.DOCX
    388 KB
    163 pages
  • National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011.pdf
    3 MB
    163 pages
  • National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011.epub
    117 KB
    163 pages